Advertisement
Advertisement
U.S. markets close in 3 hours
Advertisement
Advertisement
Advertisement
Advertisement

Acumen Pharmaceuticals, Inc. (ABOS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
6.04+0.18 (+3.03%)
As of 12:56PM EST. Market open.
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
1,436
1,697
Operating Expense
39,404
19,584
9,348
9,502
Operating Income
-39,404
-19,584
-7,912
-7,805
Net Non Operating Interest Income Expense
1,062
84
1
45
Other Income Expense
3
-81,106
586
-147
Pretax Income
-38,339
-100,606
-7,325
-7,907
Net Income Common Stockholders
-38,339
-100,606
-7,911
-7,686
Diluted NI Available to Com Stockholders
-38,339
-100,606
-7,911
-7,686
Basic EPS
-
-5.02
-0.28
-0.27
Diluted EPS
-
-5.02
-0.28
-0.27
Basic Average Shares
-
20,058
28,652
28,652
Diluted Average Shares
-
20,058
28,652
28,652
Total Operating Income as Reported
-39,404
-19,584
-7,912
-7,805
Total Expenses
39,404
19,584
9,348
9,502
Net Income from Continuing & Discontinued Operation
-38,339
-100,606
-7,325
-7,907
Normalized Income
-38,339
-19,449
-7,911
-7,760
Interest Income
1,062
84
1
45
Net Interest Income
1,062
84
1
45
EBIT
-39,404
-19,584
-7,912
-7,805
EBITDA
-39,281
-
-
-
Reconciled Depreciation
123
4
-
-
Net Income from Continuing Operation Net Minority Interest
-38,339
-100,606
-7,325
-7,907
Total Unusual Items Excluding Goodwill
0
-81,157
586
-147
Total Unusual Items
0
-81,157
586
-147
Normalized EBITDA
-39,281
61,577
-8,498
-7,658
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
Advertisement
Advertisement